海外の治験の状況「1」での検索結果
11979件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study
- Dysentery, Bacillary
- France
- 2017-03-21
Not Recruiting
- A study to evaluate the safety, reactogenicity nad immunogenicity of the GSK investigational vaccine GSK3003891A in healthy pregnant women and infants born to vaccinated mothers
- Healthy pregnant women (Respiratory Syncytial Virus) MedDRA version: 19.1 Level: PT Classification code 10061603 Term: Respiratory syncytial virus infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Australia, Canada, Finland, Honduras, New Zealand, Panama, South Africa, Spain, United Kingdom, United States
- 2017-01-31
Not Recruiting
- Observational Study of Early Interferon beta 1-a Treatment in High Risk Subjects after CIS (SET Study) - SET Study
- Clinically isolated syndrome suspected from demyelinating event (no better explanation for present symptoms)
- Czech Republic
- 2005-07-08
Authorised
- Analysis of the antibody level against interferon beta before and after increase of dose in MS therapy - Interferon beta dose and antibody
- Multiple sclerosis
- Sweden
- 2005-03-21
Not Recruiting
- A multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the safety, tolerability and efficacy of the CCR1 antagonist ZK 811752, given orally in a dose of 600 mg three times daily, for the treatment of endometriosis over 12 weeks
- Endometrial pain
- Czech Republic, Denmark, Finland, Spain, Sweden
- 2004-09-06
Not Recruiting
- Full title of the trial A Study to Assess the Efficacy and Tolerability of MK-0364 in Maintaining Weight Loss Induced by Diet in Obese Patients Followed by a 1-Year Extension - A Weight Maintenance Study of MK-0364 PN012 with 1-year Extension
- Obesity MedDRA version: 8.1 Level: LLT Classification code 10029883 Term: Obesity
- Sweden
- 2006-09-05
Not recruiting
- Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
- Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1;Diabetes Mellitus, Type 1
- Argentina, Belgium, France, Germany, India, Italy, Mexico, Puerto Rico, United States
- 2006-07-21
Not recruiting
- Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
- Amyotrophic Lateral Sclerosis
- France
- 2006-06-15
Not recruiting
- A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
- Cardiovascular Disease;Cerebrovascular Accident;Coronary Heart Disease
- Australia, Austria, Belgium, Canada, France, Germany, Ireland, Italy, Netherlands, South Africa, Spain, Switzerland, United Kingdom, United States
- 2006-05-16
Not Recruiting
- A Dose-ranging, Safety and Pharmacokinetics Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 1 to Less Than 6 Years of Age: A 4-week, Multicenter, Randomized, Double-Blind Study with a 1-year Open-label, Follow-up Period.
- Hypertension in children under the age of 6 years
- Belgium, Denmark, Germany, Italy, United Kingdom
- 2005-06-14
Not recruiting
- Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
- Nephrogenic Diabetes Insipidus
- Denmark, United States
- 2007-05-23
Not recruiting
- Effect of Ischemic Postconditioning on Targeting of Annexin A5 After Forearm Exercise
- Cardiovascular Disease;Ischemia-reperfusion Injury;Postconditioning
- Netherlands
- 2007-02-28
Not Recruiting
- Can treatment with human growth hormone increase strength in spinal muscular atrophy type II and III? - SMA-GH
- Spinal muscular atrophy (SMA) is an autosomal recessive disease. Due to the genetic defect, a molecule called “spinal motor neuron” (SMN) protein is lacking, resulting in muscle weakness. In SMAs muscle weakness is found most often at the level of proximal muscles. The disease is life-threatening and chronically debilitating.
- Germany
- 2005-11-21
Authorised
- Human pasteurized C1 esterase inhibitor concentrate (CE1145) in subjects with congenital C1-INH deficiency and acute abdominal or facial HAE attacks - C1-INH HAE study
- Hereditary angioedema (HAE) is characterized by congenital C1-INH deficiency. This is reflected by insufficient plasma concentrations of C1 – inhibitor or by synthesis of dysfunctional C1 – inhibitor molecules, which can lead to attacks of abdominal pain and/or severe swelling in the tissues e.g. of the face. Replacement with C1 esterase inhibitor concentrate is the treatment of choice of an acute attack of HAE. MedDRA version: 7.0 Level: LLT Classification code 10019860
- Bulgaria, Czech Republic, Hungary, Spain, Sweden, United Kingdom
- 2005-05-24
Authorised
- A randomised, double-blind, vehicle controlled, single centre, parallel group, comparative study of the efficacy of penciclovir 10 mg/g (1%) cream in preventing the appearance of classical lesions in recurrent cold sore sufferers. - Penciclovir 1% Cream Efficacy Study
- Cold Sores caused by the herpes simplex virus (HSV) type 1. MedDRA version: 9.1 Level: LLT Classification code 10049352 Term: Cold sores lip
- United Kingdom
- 2008-09-02
Not recruiting
- Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo
- Crohn's Disease
- Belgium, Germany, Israel, Netherlands, United States
- 2008-08-20
Not Recruiting
- A randomised sequential trial of Lithium in amyotrophic lateral sclerosis - Lithium in ALS
- Amyotrophic lateral sclerosis (ALS) is a disease characterised by progressive degeneration of motor neurons in brain and spinal cord leading to muscle weakness. ALS can occur at anytime in adulthood. Muscle weakness gradually progresses. Approximately 50% of patients die within 3 years after onset of symptoms, usually as the result of respiratory failure. To date, only one drug, i.e. riluzole, has proven to extend survival in patients with ALS, but only by approximately 3 to 6 months. MedDRA version: 9.1 Level: LLT Classification code 10052889 Term: ALS
- Netherlands
- 2008-08-05
Not Recruiting
- G-CSF (granulocyte colony stimulating factor) in liver regeneration
- Digestive System: Acute liver injury Digestive System Acute liver injury
- United Kingdom
- 2003-09-12
Not Recruiting
- Comparison between sheet grafts and 1:1 mesh grafts in burnt patients
- Injury, Occupational Diseases, Poisoning: Burns Injury, Occupational Diseases, Poisoning
- United Kingdom
- 2005-09-30
Not recruiting
- Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Germany
- 2005-09-13
